$0.0001
0[0.00%]
Last update: 11:14AM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
| Open- | Close- |
| Vol / Avg.0 / 6.870K | Mkt Cap1.784K |
| Day Range- - - | 52 Wk Range0.000 - 0.000 |
Genex Pharmaceutical Stock (OTC:GENX), Key Statistics
Genex Pharmaceutical Stock (OTC: GENX) analysis, key statistics.
Valuation Measures
Enterprise Value
110.6K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
3.9M
Total Assets
8.6M
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
90.43%
Net Margin
-8.11%
EBIT Margin
13.02%
EBITDA Margin
14.73%
Operating Margin
13.02%
Genex Pharmaceutical Stock (OTC:GENX), Key Statistics
Genex Pharmaceutical Stock (OTC: GENX) analysis, key statistics.
Valuation Measures
Enterprise Value
110.6K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
3.9M
Total Assets
8.6M
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
90.43%
Net Margin
-8.11%
EBIT Margin
13.02%
EBITDA Margin
14.73%
Operating Margin
13.02%
Genex Pharmaceutical Stock (OTC:GENX), Key Statistics
Genex Pharmaceutical Stock (OTC: GENX) analysis, key statistics.
Valuation Measures
Enterprise Value
110.6K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
3.9M
Total Assets
8.6M
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
90.43%
Net Margin
-8.11%
EBIT Margin
13.02%
EBITDA Margin
14.73%
Operating Margin
13.02%
Genex Pharmaceutical Stock (OTC:GENX), Key Statistics
Genex Pharmaceutical Stock (OTC: GENX) analysis, key statistics.
Valuation Measures
Enterprise Value
110.6K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
3.9M
Total Assets
8.6M
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
90.43%
Net Margin
-8.11%
EBIT Margin
13.02%
EBITDA Margin
14.73%
Operating Margin
13.02%
Genex Pharmaceutical Stock (OTC:GENX), Key Statistics
Genex Pharmaceutical Stock (OTC: GENX) analysis, key statistics.
Valuation Measures
Enterprise Value
110.6K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
3.9M
Total Assets
8.6M
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
90.43%
Net Margin
-8.11%
EBIT Margin
13.02%
EBITDA Margin
14.73%
Operating Margin
13.02%
Genex Pharmaceutical Stock (OTC:GENX), Key Statistics
Genex Pharmaceutical Stock (OTC: GENX) analysis, key statistics.
Valuation Measures
Enterprise Value
110.6K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
3.9M
Total Assets
8.6M
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
90.43%
Net Margin
-8.11%
EBIT Margin
13.02%
EBITDA Margin
14.73%
Operating Margin
13.02%
Genex Pharmaceutical Stock (OTC:GENX), Key Statistics
Genex Pharmaceutical Stock (OTC: GENX) analysis, key statistics.
Valuation Measures
Enterprise Value
110.6K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
3.9M
Total Assets
8.6M
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
90.43%
Net Margin
-8.11%
EBIT Margin
13.02%
EBITDA Margin
14.73%
Operating Margin
13.02%
Genex Pharmaceutical Stock (OTC:GENX), Key Statistics
Genex Pharmaceutical Stock (OTC: GENX) analysis, key statistics.
Valuation Measures
Enterprise Value
110.6K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
3.9M
Total Assets
8.6M
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
90.43%
Net Margin
-8.11%
EBIT Margin
13.02%
EBITDA Margin
14.73%
Operating Margin
13.02%